Kenneth Myszkowski - Jan 1, 2022 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Chief Financial Officer
Signature
/s/ Kenneth Myszkowski
Stock symbol
ARWR
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 08:25 PM
Next filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Award $0 +60K +13.51% $0.00 504K Jan 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.
F2 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.